Helius Medical Technologi...

NASDAQ: HSDT · Real-Time Price · USD
4.35
0.05 (1.16%)
At close: May 09, 2025, 3:55 PM
4.20
-3.45%
After-hours: May 09, 2025, 04:00 PM EDT

Helius Medical Statistics

Share Statistics

Helius Medical has 528.06K shares outstanding. The number of shares has increased by -7.36% in one year.

Shares Outstanding 528.06K
Shares Change (YoY) -7.36%
Shares Change (QoQ) -7.2%
Owned by Institutions (%) 0.02%
Shares Floating n/a
Failed to Deliver (FTD) Shares 217
FTD / Avg. Volume 1.83%

Short Selling Information

The latest short interest is 17.33K, so 0.46% of the outstanding shares have been sold short.

Short Interest 17.33K
Short % of Shares Out 0.46%
Short % of Float 0.47%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -2.32 and the forward PE ratio is -11.83. Helius Medical's PEG ratio is 0.03.

PE Ratio -2.32
Forward PE -11.83
PS Ratio 52.37
Forward PS 0
PB Ratio 25.72
P/FCF Ratio -2.47
PEG Ratio 0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Helius Medical.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.01.

Current Ratio 1.58
Quick Ratio 1.1
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $24,761.9
Profits Per Employee $-559,142.86
Employee Count 21
Asset Turnover 0.15
Inventory Turnover 0.56

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -83.14% in the last 52 weeks. The beta is 1.11, so Helius Medical's price volatility has been higher than the market average.

Beta 1.11
52-Week Price Change -83.14%
50-Day Moving Average 5.46
200-Day Moving Average 8.63
Relative Strength Index (RSI) 43.23
Average Volume (20 Days) 11,869

Income Statement

In the last 12 months, Helius Medical had revenue of 520K and earned -11.74M in profits. Earnings per share was -4.33.

Revenue 520K
Gross Profit -62K
Operating Income -13.9M
Net Income -11.74M
EBITDA -13.8M
EBIT -13.86M
Earnings Per Share (EPS) -4.33
Full Income Statement

Balance Sheet

The company has 1.09M in cash and 12K in debt, giving a net cash position of 1.08M.

Cash & Cash Equivalents 1.09M
Total Debt 12K
Net Cash 1.08M
Retained Earnings -171.7M
Total Assets 3.48M
Working Capital 1.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.04M and capital expenditures -5K, giving a free cash flow of -11.05M.

Operating Cash Flow -11.04M
Capital Expenditures -5K
Free Cash Flow -11.05M
FCF Per Share -4.08
Full Cash Flow Statement

Margins

Gross margin is -11.92%, with operating and profit margins of -2673.65% and -2258.08%.

Gross Margin -11.92%
Operating Margin -2673.65%
Pretax Margin -2258.08%
Profit Margin -2258.08%
EBITDA Margin -2654.42%
EBIT Margin -2673.65%
FCF Margin -2124.23%

Dividends & Yields

HSDT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for HSDT is $24, which is 458.1% higher than the current price. The consensus rating is "Buy".

Price Target $24
Price Target Difference 458.1%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Stock Splits

The last stock split was on May 2, 2025. It was a backward split with a ratio of 1:15.

Last Split Date May 2, 2025
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score -82.98
Piotroski F-Score 2